Overview
Bart De Strooper co-founded Augustine Therapeutics alongside Ludo Van Den Bosch and Joris De Wit, researchers with strong academic credentials in neuroscience. The company raised EUR 77.7M in a Series A round in H1 2025, one of the larger biotech rounds in recent Belgian history, with participation from PMV and other investors.
Career history
Related profiles
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.